Language development with cochlear implants and speech-language therapy in young children
Official title: Language Development in Children With Cochlear Implants and Speech-language Therapy Interventions
Run by Assistance Publique - Hôpitaux de Paris · NCT07447427 · Data updated 2026-11-12
This study looks at how speech-language therapy, either auditory-phonological or auditory-verbal, helps young children with severe to profound prelingual hearing loss who have cochlear implants.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 32 Months to 48 Months |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris, Île-de-France Region) |
| Status | Recruiting |
| Started | April 17, 2026 |
| Main results expected | April 17, 2028 |
| Study ends | May 17, 2028 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07447427 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children with severe to profound prelingual hearing loss who receive cochlear implants between 8 and 24 months of age and have at least 24 months of follow-up.
✕Probably not a fit
Children with progressive hearing loss, significant neurological conditions, or suspected autism may not experience the same benefits from these therapy approaches.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines how different speech-language therapy approaches, used alongside cochlear implants in children with severe to profound prelingual hearing loss, affect early language development. It compares parent-centered auditory-verbal therapy with knowledge of auditory stimulation to support oral language, against approaches that incorporate visual language supports. The study follows implanted children from 8 to 24 months of age and tracks outcomes for at least two years post-implantation. Therapy is delivered as part of standard care, with recruitment and follow-up conducted at a Paris-area pediatric center. The goal is to understand real-world language outcomes under these commonly used rehabilitative strategies.
Why it matters
Potential benefit: If successful, the findings could inform best practices for pairing cochlear implantation with effective speech-language therapy to optimize early language outcomes.
How similar studies have gone: Prior guidelines support early auditory interventions and parental involvement, but direct comparative evidence between AVT and AP-like approaches in this specific population remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with severe to profound prelingual hearing loss * Implanted between 8 and 24 months of age * At least 24 months of follow-up after implantation * No parental objection from legal guardians Exclusion Criteria: * Children with progressive hearing loss * Severe neurological pathology, identified by MRI and/or neuro-pediatric assessment * Suspected or diagnosed Autism Spectrum Disorder (ASD)
Where it's running
-
Hôpital Necker - Enfants Malades - Service d'ORL et chirurgie cervico-faciale
Paris, Île-de-France Region, France Recruiting
Study contacts
- Principal investigator: Iris ATTAL — Hôpital Necker - Enfants Malades -Service d'ORL et chirurgie cervico-faciale
- Study coordinator: Iris ATTAL
- Email: iris.attal@aphp.fr
- Phone: 01 44 49 46 87
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
-
How Eye Dominance Affects Fusion in Healthy Adults
This study tests whether fusional vergence measurements differ when tested on the dominant eye versus the non-dominant eye in healthy adults.
-
Breast cancer risk check for night shift workers with a personalized prevention plan
This study tests whether a personalized prevention plan helps female night shift workers at higher risk for breast cancer stick to healthier habits and screening over 5 years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.